Submit Content
Get the latest delivered to your inbox
Privacy Policy

Livestream: Biogen’s New Corporate Commitment to Climate, Health and Equity

Join Biogen and other leading institutions for an important discussion on climate, health, and equity

Published 09-10-20

Submitted by Biogen

Health or the economy? Climate or jobs? Equity or affordability?

These questions define our time and will be debated during Climate Week and beyond. 

But what if we don’t have to choose? Biogen believes it is time to usher in a new era of “both / and” climate commitments.

Register now for an insider’s look at Biogen’s major new corporate commitment to climate, health and equity.

September 14th, 10am EST via Zoom

REGISTER

Biogen Logo

Biogen

Biogen

At Biogen, our mission is clear: we are pioneers in neuroscience. Biogen discovers, develops and delivers worldwide innovative therapies for people living with serious neurological and neurodegenerative diseases as well as related therapeutic adjacencies. One of the world’s first global biotechnology companies, Biogen was founded in 1978 by Charles Weissmann, Heinz Schaller, Kenneth Murray and Nobel Prize winners Walter Gilbert and Phillip Sharp. Today Biogen has the leading portfolio of medicines to treat multiple sclerosis, has introduced the first approved treatment for spinal muscular atrophy, commercializes biosimilars of advanced biologics and is focused on advancing research programs in multiple sclerosis and neuroimmunology, Alzheimer’s disease and dementia, neuromuscular disorders, movement disorders, ophthalmology, immunology, neurocognitive disorders, acute neurology and pain. We routinely post information that may be important to investors on our website at www.biogen.com. To learn more, please visit www.biogen.com and follow us on social media - Twitter, LinkedIn, Facebook, YouTube.

More from Biogen

Join today and get the latest delivered to your inbox